Trial register facet
Trial records for Danuglipron
8 records for Danuglipron, of which 2 are published trials.
Showing 0 records on this page
Records
8 documents
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| DANU-PH2B-OBESITY | Danuglipron | Phase 2b | Programme discontinued | Randomised, double-blind, placebo-controlled | 605 | 2023 | Not rated |
| DANU-PH2B-T2D | Danuglipron | Phase 2b | Programme discontinued | Randomised, double-blind, placebo-controlled | 411 | 2023 | Not rated |
| DANU-PH2B-OBESITY-QOLprogramme record | Danuglipron | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |
| DANU-PH2B-T2D-BODY-COMPprogramme record | Danuglipron | Phase 2b | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |
| DANU-PH2B-OBESITY-REGIONAL-CNprogramme record | Danuglipron | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |
| DANU-PH2B-T2D-REGIONAL-JPprogramme record | Danuglipron | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |
| DANU-PH2B-OBESITY-REGIONAL-JPprogramme record | Danuglipron | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |
| DANU-PH2B-T2D-REGIONAL-CNprogramme record | Danuglipron | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2023 | Very low |